Exagen Inc. XGN PP&E (Gross)
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s pp&e (gross).
Connect your AI assistant and see it in context, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Exagen Inc.'s PP&E (gross)?
- Exagen Inc. (XGN) reported PP&E (gross) of $14.35M in Q1 2026.
- How has Exagen Inc.'s PP&E (gross) changed year-over-year?
- Exagen Inc.'s PP&E (gross) increased by 29.0% year-over-year, from $11.12M to $14.35M.
- What is the long-term trend for Exagen Inc.'s PP&E (gross)?
- Over 4 years (2021 to 2025), Exagen Inc.'s PP&E (gross) has grown at a 12.9% compound annual growth rate (CAGR), from $8.66M to $14.08M.
- What does PP&E (gross) mean?
- Total cost of all property, plant, and equipment before deducting accumulated depreciation — the gross investment in tangible assets.